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BACKGROUND: Secreted factors contained in conditioned media (CM) of human umbilical cord blood mesenchymal stem cells (hUCB-MSCs) 
known as secretome, was suspected to have important roles 
in regulating cells.  This study was conducted to investigate 
the role of CM-hUCB-MSCs-derived secretome in apoptosis 
and growth of HeLa cells.
METHODS: HeLa cells were treated with secretome 
in various concentrations (0, 0.2, 2 and 20%) for 24 and 
48 hours. Trypan blue exclusion assay was performed to 
detect cell viablity. Meanwhile sub-G1 apoptotic assay 
was performed to detect apoptotic cells. The transition 
of mitochondrial transmembrane potential (TMP), 
which occurs in the apoptotic process, was analyzed by 
mitochondrial membrane potential (ΔΨM) assay.  Both 
sub-G1 and ΔΨM assays were performed using FACSCanto 
flow cytometer. Statistical analyses were conducted using 
IBM SPSS Statistics to detect significance level at p<0.05.
RESULTS: Secretome significantly induced cell death 
starting at concentration of 0.2% within a 24-hour period 
(p<0.05). Secretome significantly induced cell death in 
concentration and time dependent manner (p<0.05). The 
cell death was then confirmed as apoptosis through sub-G1 
analysis. Due to the underlying apoptotic mechanism, we 
found distinct decrease of TMP, indicating an increase in 
mitochondrial membrane permeability of HeLa cells. In 
LATAR BELAKANG: Sekretom merupakan berbagai faktor yang disekresikan oleh sel punca mesenkimal darah tali pusat yang terkandung 
dalam media yang dikondisikan. Sekretom diperkirakan 
memiliki peran penting dalam meregulasi sel. Studi berikut 
dilakukan untuk mengetahui peran sekretom dalam induksi 
apoptosis dan hambatan pertumbuhan pada sel HeLa.
METODE: Sel HeLa diberi perlakuan dengan sekretom 
pada konsentrasi yang bervariasi (0, 0,2, 2 dan 20%) selama 
24 dan 48 jam. Pemeriksaan trypan blue exclusion dilakukan 
untuk mendeteksi viabilitas sel. Sedangkan pemeriksaan 
sub-G1 dilakukan untuk mendeteksi sel yang mengalami 
apoptosis. Transition of mitochondrial transmembrane 
potential (TMP) dapat terjadi pada proses apoptosis 
yang dapat dianalisis dengan pemeriksaan mitochondrial 
membrane potential (ΔΨM). Pemeriksaan sub-G1 dan 
ΔΨM dilakukan menggunakan alat FACSCanto flow 
cytometer. Analisis statistik dilakukan dengan mendeteksi 
level signifikan pada p<0,05.
HASIL:  Sekretom secara signifikan (p<0,05) menginduksi 
kematian sel berawal dari konsentrasi 0,2% dalam waktu 
24 jam. Sekretom secara signifikan (p<0,05) menginduksi 
kematian sel bergantung pada konsentrasi sekretom dan 
waktu perlakukan. Kematian sel tersebut merupakan proses 
apoptosis yang dikonfirmasikan dengan pemeriksaan 
sub-G1. Terkait mekanisme apoptosis yang ditimbulkan, 
Abstract Abstrak
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Methods
Mesenchymal stem cells (MSCs) have been defined as 
a major type of non-haematopoietic cells that display 
a potential to self-renew and to undergo multilineage 
differentiation due to the multipotent capacity and are thus 
an attractive source of stem cells for tissue engineering.(1) 
Based on the number of cells, accessibility and research 
reports, there are three MSCs main sources for clinical 
use: bone marrow, adipose tissue and umbilical cord blood 
(UCB).(2) MSCs derived from these sources exhibited 
minimum MSCs criteria according to the International 
Society for Cell Therapy (ISCT) which are: 1) adherence 
to plastic in standard culture conditions; 2) specific 
surface antigen expression, i.e. positive expression (≥ 95% 
positive) of cluster of differentiation (CD)105, CD73, 
CD90 expressions, and lack expression (≤ 2% positive) of 
CD45, CD34, CD14 or CD11b, CD79a or CD19 and human 
leukocyte antigen (HLA)-DR; 3) the ability to differentiate 
into osteoblasts, adipocytes, chondroblasts under standard 
in vitro differentiating conditions.(2,3)
 Human UCB (hUCB) is considered as the most suitable 
source of MSCs because it has less ethical complications, 
and easy to isolate via non-invasive methods.(1) It has been 
reported that neonatal MSCs have lower immunogenicity and 
stronger immunosuppressive capacity which indicates that 
they are more suitable for therapeutic approaches.(1) MSCs 
participate in the structural and functional maintenance of 
connective tissues under normal homeostasis and also act as 
trophic mediators during tissue repair, generating bioactive 
molecules that help in tissue regeneration following injury.
(4,5) 
addition, we found that HeLa cell growth was inhibited 
partially by secretome.
CONCLUSION: Taken together, we conclude that CM-
hUCB-MSCs-derived secretome significantly induced 
apoptosis of HeLa cells in a concentration and time 
dependent manner through mitochondrial apoptotic 
pathway. The secretome might also play important role in 
inhibiting HeLa cell growth.
KEYWORDS: umbilical cord blood, mesenchymal stem 
cell, secretome, apoptosis, growth, cancer
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kami menemukan adanya penurunan TMP yang berarti 
terjadinya peningkatan permeabilitas membran mitokondria 
pada sel HeLa. Selain itu, pertumbuhan sel HeLa juga 
mengalami inhibisi secara parsial oleh sekretom.
KESIMPULAN: Sekretom yang disekresikan oleh sel 
punca mesenkimal darah tali pusat yang terkandung dalam 
media yang dikondisikan ini, secara signifikan menginduksi 
apoptosis sel HeLa dan berkorelasi dengan konsentrasi 
sekretom dan lama perlakuan. Apoptosis yang ditimbulkan 
merupakan jalur apoptosis mitokondria. Sekretom juga 
berperan dalam menghambat pertumbuhan sel HeLa.
KATA KUNCI: darah tali pusat, sel punca mesenkimal, 
sekretom, apoptosis, pertumbuhan, kanker
Introduction  More recently, MSCs have become a topic of great focus in relation to the cancer. Growing evidence suggests 
that MSCs home to not just injured tissues but tumors, 
where they have an important role in affecting the behavior 
of tumor cells.(6) MSCs are known to secrete a broad 
panel of proteins including growth factors, chemokines 
and cytokines, which are called secretome.(7) It has been 
reported that secretome contained in conditioned media 
(CM) of MSCs promotes apoptosis and autophagy of cancer 
cells.(8) Tumor Necrosis Factor (TNF)-α, Transforming 
Growth Factor (TGF)-β, and Interferon (IFN)-γ are known 
to influence cell cycle regulation, as well as induce growth 
attenuation and apoptosis in cancer cells.(8) Despite 
some evidences demonstrate that MSCs can suppress 
tumorigenesis, others show that MSCs favor tumor growth.
(9,10) Since the role of MSCs on tumors remains unclear, 
we conducted an in vitro study to investigate the effect of 
hUCB-MSCs on HeLa cells.
Cell culture and CM of hUCB-MSCs (CM-hUCB-
MSCs)-derived secretome preparation
HeLa cells were cultured in Dulbecco’s Modified Eagle 
Medium containing 10% fetal bovine serum, penicillin, 
streptomycin, and amphotericin B. Meanwhile, hUCB-
MSCs (3H Biomedical AB, Uppsala, Sweden) were 
cultured in Mesencult media (StemCell Technologies Inc., 
Vancouver, Canada) containing penicillin and streptomycin. 
Upon reaching 80% confluency, hUCB-MSCs media was 
replaced with supplement-free media and incubated for 
24 hours. Media was collected and centrifuged. Resulted 
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Results
Secretome partially inhibited the growth and induced 
the apoptosis of HeLa cells
Lower cell density of secretome-treated HeLa cells was 
observed (Figure 1A-D). The lower HeLa cells density was 
observed started from treatment of 0.2% secretome (Figure 
1B). Meanwhile, 20% secretome-treated HeLa cells had the 
lowest cell density. We also found that cells treated for 48 
supernatant was used as CM-hUCB-MSCs-derived 
secretome.
Trypan blue exclusion assay
Treated cells were harvested and stained with trypan 
blue.  Cell morphology and calculation were observed 
using hemocytometer under an inverted light microscope. 
Membrane integrity of apoptotic cell can be demonstrated 
by the exclusion of this dye. Viable cells will appear clear 
whereas dead cells will appear blue.
Sub-G1 analysis
Sub-G1 analysis was performed as described previously. 
(11,12) Treated cells were harvested and suspended in 1 ml 
of hypotonic fluorochrome solution (50 μg/ml propidium 
iodide in 0.1% sodium citrate containing 0.1% Triton 
X-100). Cell suspensions were placed at 4°C in the dark, 
overnight before flow cytometric analysis. The propidium 
iodide fluorescence of individual nuclei was measured using 
a FACSCanto II flow cytometer (Becton Dickinson & Co, 
Franklin Lakes, NJ, USA).
ΔΨM analysis
ΔΨM analysis was performed as described previously. 
(11,12) After treatment, cells were harvested and suspended 
in 250 μl of 20 nM 3,3'-Dihexyloxacarbocyanine Iodide 
(DiOC
6
) in Phosphate-Buffered Saline (PBS) and incubated 
in an incubator for 15 minutes. ΔΨM was measured using a 
FACSCanto flow cytometer.
Statistical analysis
Statistical analyses were performed using IBM SPSS 
Statistics for Macintosh version 21 (SPSS IBM, Armonk, 
NY, USA). One way Analysis of Variance (ANOVA) was 
used to compare means of two or more groups. Unpaired 
t-test and Mann-Whitney test was used to compare two 
populations means. Two-way ANOVA was used to compare 
means of groups with more than two factors. Statistically 
significance is expressed as p<0.05.
Figure 1. HeLa cells density under treatment of secretome. 
In 6-well culture plate, 6x104 HeLa cells were seeded, starved 
and treated with 0 (A), 0.2 (B), 2 (C) and 20% (D) for 24 and 48 
hours. H
2
O
2
 (E) was used as positive control for apoptosis inducing 
activity. HeLa cells were observed and captured under an inverted 
light microscope. White bar: 100 μm.
hours have lower density compared with 24 hours. These 
results showed that HeLa cells density was regulated by 
secretome in concentration and time dependent manner. 
 When we performed cell counting, HeLa cells treated 
with higher concentration and longer treatment period had 
lower total cell population. This result suggested that the 
growth of HeLa cells was inhibited partially by secretome 
in a concentration and time dependent manner. By Mann-
Whitney test, we found significant differences between total 
population of the cells treated with 0% secretome and the 
ones treated with 0.2%, 2%, 20% secretome in the period 
of 24 hours (p=0.02; p=0.001; p=0.001 respectively). We 
also found significant differences between total population 
of the cells treated with 0% secretome and the ones treated 
with 0.2%, 2%, 20% secretome in the period of 48 hours 
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was obtained for the cells treated with 0.2% secretome. 
Similar results were also found for the cells treated with 
2% or 20% secretome (p<0.05, Unpaired t-test). Secretome-
caused cell death was significantly different between 
concentrations in both 24 and 48 hours treatment (p<0.05, 
ANOVA). The post-hoc analysis showed that secretome 
significantly induced cell death starting at concentration of 
0.2% within a 24-hour period (p<0.05). Two-way ANOVA 
analysis results showed that secretome induced cell death in 
concentration and time dependent manner (p<0.05).
 By performing Sub-G1 analysis, the secretome-caused 
cell death was confirmed as apoptosis. The results showed 
an increase of M1 area, indicating an increase of apoptotic 
cells along with the increase of secretome concentrations 
(Figure 2). The highest percentage of apoptotic cells at 55% 
was found at the treatment of 20% secretome for 48 hours. 
The secretome-caused apoptosis in concentration dependent 
manner is consistent with the result of cell counting with 
trypan blue exclusion assay.
Figure 2.  Flow cytometry detection of apoptotic cells. HeLa 
cells were seeded, starved, and treated with CM-hUCB-MSCs-
derived secretome at 0 (A), 0.2 (B), 2 (C), and 20% (D) for 48 
hours. Apoptosis quantification was performed according to 
Sub-G1 analysis as described in “Material and Methods”. PI: 
Propidium Iodide; M1: sub-G1 area.
(p=0.001; p=0.000; p=0.000 respectively, Unpaired t-test).
 Higher trypan blue-stained dead cell number was 
found in the cells treated with secretome for 48 hours 
compared with the ones treated for 24 hours (Table 1&2). 
Significant cell death difference between 24 and 48 hours 
Figure 3. HeLa cells mitochondrial membrane permeabiliza-
tion. HeLa cells were seeded, starved, and treated with CM-hUCB-
MSCs-derived secretome at 0 (A), 0.2 (B), 2 (C), and 20% (D) for 
24 and 48 hours. TMP was assayed by ΔΨM analysis as described 
in “Material and Methods”. Red arrow shows the amount of HeLa 
cells with TMP loss. 
0% 0.20% 2% 20%
Viable 
(Mean ± SD)
Dead           
(Mean ± SD)
Total 177,500 139,375* 126,875* 126,250*
11,875 ± 1,767 24,063 ± 4,419 31,563 ± 1,860 40,625 ± 2,587
Viability
CM-hUCB-MSCs-derived Secretome
165,625 ± 23,480 115,313 ± 8,602 95,313 ± 12,059 85,625 ± 7,989
Table 2. HeLa cells viability under treatment of CM-hUCB-
MSCs-derived secretome for 48 hours.
*: Unpaired t-test, p<0.05; total population of the cells treated with 
0% secretome was compared with the ones treated with 0.2, 2 and 
20% secretome.
0% 0.20% 2% 20%
Viable 
(Mean ± SD)
Dead           
(Mean ± SD)
Total 158,750 136,250* 117,188* 108,750*
11,563 ± 2,969 20,313 ± 2,814 24,063  ± 2,290 25,000 ± 1,889
Viability
CM-hUCB-MSCs-derived Secretome
147,188 ± 19,385 115,938 ± 13,156 93,125 ± 9,977 83,750 ± 9,354
Table 1. HeLa cells viability under treatment of CM-hUCB-
MSCs-derived secretome for 24 hours.
*: Mann-Whitney test, p<0.05; total population of the cells treated 
with 0% secretome was compared with the ones treated with 0.2, 
2 and 20% secretome.
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mitochondrial pathway in concentration and time dependent 
manner. 
 The crucial event in mitochondrial apoptotic pathway is 
the mitochondrial outer-membrane permeabilization which 
releases numerous pro-apoptotic proteins into the cytosol.
(11,12,17) Pro-apoptotic protein such as cytochrome-c will 
activate the caspase-dependent mitochondrial apoptotic 
pathway by its binding with Apoptotic protease-activating 
factor 1 (Apaf-1) as well as procaspase-9, forming an 
apoptosome.(16,18) Apoptosome cause the activation of 
caspase-9, which subsequently activates the caspase-3 
through proteolytic processing.(18-20) 
 It is known that hUCB-MSCs secrete various growth 
factors, inflammatory cytokines and chemokines, and 
express receptors and/or counter-receptors both for cell-cell 
and cell-matrix intervention.(21) Some research reported 
that several cytokines and chemokines from MSCs such as 
C-X-C motif chemokine 10 (CXCL10), IFN-γ-inducible 
protein (IP)-10, interleukin (IL)-6, IL-8, IFN-1β, and TNF-α 
played an important role in inhibiting proliferation of cancer 
cells in vitro.(22) Other reports have stated that TNF-α, 
TGF-β and IFN-γ affect cell cycle regulation in cancer cells 
by causing cell growth attenuation and induce apoptosis.
(10) Thus, it is likely that secretome induced apoptosis and 
inhibited growth of HeLa cells.
Conclusion
Taken together, we conclude that CM-hUCB-MSCs-
derived secretome significantly induced apoptosis of 
HeLa cells in a concentration and time dependent manner 
through mitochondrial apoptotic pathway. CM-hUCB-
MSCs-derived secretome might also play important role in 
inhibiting HeLa cell growth. Further investigations should 
be pursued to confirm the presence of mitochondrial pro-
apoptotic and growth inhibiting factors in secretome.
Discussion
It has been reported that MSCs have the ability to inhibit 
proliferation and induce apoptosis of cancer cells. Recent 
study reported that CM derived from human Wharton’s jelly 
stem cells promotes cancer cells apoptosis and autophagy.
(13) Meanwhile another study reported that CM of bone 
marrow MSCs promotes the growth of breast cancer cells 
in mouse.(14) The controversy that MSCs exhibit pro- or 
anti-proliferative effects on growth of tumor cells might 
be interpreted by the malignant cell type being studied; the 
interaction fashion between MSCs and the tumor cells; and 
the cell number of MSCs used. In addition, different MSCs 
sources might be associated with different effects on the 
tumor growth.(10) Although MSCs derived from different 
sources share many characteristics features, they differ in 
many aspects of gene expression profile and physiology.(15)
 In this study, cell density of HeLa cells population was 
lower when treated at higher concentration of secretome. We 
also found higher cell density in 24-hour treatment period, 
compared with the one treated for 48 hours. By trypan 
blue exclusion assay, we found the lower cell density was 
due to lower cell population growth and higher cell death. 
Cell death was then confirmed as apoptosis according to 
Sub-G1 results. Our results showed that, besides having the 
potential to partially inhibit cell growth, CM-hUCB-MSCs-
derived secretome also has the ability to induce HeLa cells 
apoptosis in concentration and time dependent manner. 
 The reduction of cells TMP indicating permeabilized 
mitochondrial membrane (16), was observed in secretome-
treated HeLa cells. We found that cells TMP was reduced 
when treated with higher concentration and longer 
treatment period of secretome. These results suggested that 
CM-hUCB-MSCs-derived secretome increased the number 
of HeLa cells in the initiation phase of apoptosis through 
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Transition of mitochondrial transmembrane potential 
(TMP) loss of HeLa cells treated with CM-hUCB-MSCs-
derived secretome 
To study the mechanism involved in secretome-induced 
HeLa cells apoptosis, TMP was investigated by ΔΨM 
analysis. In mitochondrial apoptotic pathway, loss of TMP 
is largely due to the opening of mitochondrial permeability 
transition pores, reflected by the loss of DiOC
6
 fluorescence. 
Higher cell number with low TMP was observed in HeLa 
cells treated with 20% secretome for 48 hours compared 
with the one treated for 24 hours (Figure 3D). These 
results proved that secretome reduced HeLa cells TMP in 
concentration and time dependent manner.
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